Orion Infusion Limited (DSE:ORIONINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
383.90
+14.60 (3.95%)
At close: Mar 4, 2026
Market Cap7.82B +5.6%
Revenue (ttm)665.43M -15.0%
Net Income37.47M -9.9%
EPS1.84 -9.9%
Shares Out20.36M
PE Ratio208.61
Forward PEn/a
Dividend2.00 (0.54%)
Ex-Dividend DateDec 2, 2025
Volume1,047,262
Average Volume450,377
Open369.30
Previous Close369.30
Day's Range367.50 - 385.00
52-Week Range303.30 - 587.50
Beta-2.36
RSI57.23
Earnings DateApr 29, 2026

About Orion Infusion

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isoto... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1983
Employees 563
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ORIONINFU
Full Company Profile

Financial Performance

In fiscal year 2025, Orion Infusion's revenue was 664.92 million, a decrease of -19.64% compared to the previous year's 827.42 million. Earnings were 35.02 million, a decrease of -17.27%.

Financial Statements